Aetna CEO and Chairman Mark Bertolini talked to CNBC about earnings, drug prices and needed changes to Obamacare. » Read More
Traders on Friday will comb through the first of two key employment reports that could determine the likelihood of a rate hike in December.
Markets will be laser-focused on Friday's October jobs report in the week ahead and may even look past more than a dozen scheduled Fed speeches.
As the third-quarter earnings season gets underway, a group of stocks could be ready to pop, if history is any guide.
In a letter to clients, Glenview's Larry Robbins addressed recent losses, defended his health-care positions and offered a new no-fee fund vehicle.
Walgreens' acquisition of Rite Aid would combine two of the largest U.S. drugstore chains.
The deal, which could be announced Wednesday, would combine the second-and-third largest U.S. drugstore chains, according to reports.
While headlines are dominated by the debate over drug pricing and business models, the real issue for healthcare may be that business is slowing.
U.S. stocks closed lower Tuesday, with the Dow Jones industrial average snapping a three-day winning streak.
Some of the names on the move ahead of the open.
U.S. stock futures were lower this morning, due in part to a disappointing earnings report from Dow stock IBM.
U.S. stock futures were lower this morning, after Wall Street capped a third straight winning week.
Shareholders will get their say on two big deals: Aetna's $37B bid for Humana, and Centene's $6.3B bid for Health Net.
Since the Oct. 1 launch of the nation's new medical coding billing system known as ICD-10, vendors say so far so good.
Take a look at some of Tuesday's early movers: YUM, AET, STZ, DIS, PG, MSFT & more
Large insurers raised prices at a higher rate than smaller ones, and provider-owned plans tended to be more expensive, two studies found.
August and September are historically the worst months of the year for stocks. So what's an investor to do? Here's a playbook.
Katrina enabled Ochsner Baptist to hit the "reset button," said Ochsner Health System CEO Warner Thomas.
Mergers and acquisitions have set a blistering pace this year, and that is unlikely to slow until shareholders stop rewarding deals.
With global dealmaking this year expected to exceed the record levels of 2007, Lazard Vice Chairman Gary Parr tells CNBC why he's not worried about froth.
A couple of big health-insurance mergers could have a very positive side effect, says consultant Jon Kaplan.